<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00512330</url>
  </required_header>
  <id_info>
    <org_study_id>LAM ELISA in childhood TB</org_study_id>
    <nct_id>NCT00512330</nct_id>
  </id_info>
  <brief_title>Lipoarabinomannan (LAM) Enzyme-Linked Immunosorbent Assay (ELISA) in Diagnostics of Childhood Tuberculosis (TB)</brief_title>
  <official_title>Evaluation of Urine Lipoarabinomannan ELISA In Diagnostics of Childhood Tuberculosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bonn</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Our Lady of Mount Carmel Community Hospital, Kapiri, Malawi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Health and Population, Malawi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mbeya Medical Research Programme, Mbeya, Tanzania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Unterstützerkreis Missionskrankenhaus Kapiri e.V., Munich, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Foerderverein AIDS im Kindesalter in Bonn e.V., Bonn, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children`s Medical Hospital, University of Bonn, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Bonn</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In children, it remains quite difficult even in developed countries, to prove a diagnosis of
      Tuberculosis (TB). New means for diagnosis of this disease are currently being researched.
      One candidate test is Lipoarabinomannan ELISA from Urine, which has shown good sensitivity of
      up to 80% in adults.

      Our study aims to evaluate this test in the diagnosis of children with TB.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Among candidate new diagnostics for TB, a test for mycobacterial Lipoarabinomannan (LAM)
      excretion in urine has shown promising results in one Tanzanian study: The sensitivity for
      detecting TB culture-positive patients was 80.3%. Of 103 healthy volunteers, only one gave a
      false positive result (Boehme, 2005).

      Until now, there are only data concerning this test for diagnosis of adult disease. For
      evaluation of routine use in children in countries like Malawi, we are starting a prospective
      study. Children 0-14 years of age with suspected TB will be investigated using TB culture as
      the gold standard. In sputum samples, microscopy will be done. Simultaneously, LAM Elisa from
      the patient´s urine will be done.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2007</start_date>
  <completion_date type="Anticipated">August 2008</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Tuberculosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Children up to 14 years of age with suspicion of TB
      </textblock>
    </study_pop>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 0-14 years

          -  suspicion of active TB or TB contact

        Exclusion Criteria:

          -  no informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Norbert Heinrich, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Bonn</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Chimphamba, Clinical Officer</last_name>
    <role>Principal Investigator</role>
    <affiliation>Our Lady of Mount Carmel Hospital, Kapiri</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andreas Mueller, PD Dr med.</last_name>
    <role>Study Chair</role>
    <affiliation>University of Bonn</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Norbert Heinrich, MD</last_name>
    <phone>0049 179 7044231</phone>
    <email>norbert.heinrich@ukb.uni-bonn.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>John Chimphamba, Clinical Officer</last_name>
    <phone>00265 9394287</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Our Lady of Mount Carmel Hospital</name>
      <address>
        <city>Kapiri/Mchinji</city>
        <state>Mchinji</state>
        <country>Malawi</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>John Chimphamba, Clinical Officer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Malawi</country>
  </location_countries>
  <verification_date>August 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 6, 2007</study_first_submitted>
  <study_first_submitted_qc>August 6, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2007</study_first_posted>
  <last_update_submitted>August 5, 2008</last_update_submitted>
  <last_update_submitted_qc>August 5, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 6, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr. Norbert Heinrich, Principal Investigator</name_title>
    <organization>Department of Tropical Medicine, Ludwig-Maximilan-University, Munich, Germany</organization>
  </responsible_party>
  <keyword>childhood</keyword>
  <keyword>tuberculosis</keyword>
  <keyword>diagnostic</keyword>
  <keyword>lipoarabinomannan</keyword>
  <keyword>ELISA</keyword>
  <keyword>Tuberculosis in Childhood</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

